Title: OBI-992, a novel TROP2 targeting antibody-drug conjugate, displayed excellent antitumor efficacy in various animal models
Abstract presentation number: 1893 / Poster number 23/4
Title: In vitro characterization of a novel TROP2-targeting antibody-drug conjugate OBI-992
Abstract presentation number: 3130 / Poster number 21/11
Title: Development of a novel site-specific ADC glycan platform with potential for improved in vivo efficacy and stability of the ADC in animal studies
Abstract presentation number: 3149 / Poster number 21/30
Title: OBI-992, a novel TROP2 targeting antibody drug conjugate demonstrates superior in vivo PK/PD properties and a favorable safety profile
Abstract presentation number: 7179 / Poster number 24/20
